Medical Dynamics

Partnering Inflammation/Autoimmune Drugs Offers Sizzle And Steak (The Pink Sheet)

This is copyright protected information, to receive the full article, please click here to sign up and register.

BioMarin treatment gets special FDA status (CNBC)

US Senate health reform battle begins (PharmaTimes)

Merck KGaA Shares Slide on FDA Setback for Cladribine MS Pill (Bloomberg)

Pediatric Exclusivity For Brand Biologics Added In Senate FOB Provision, But Generics Have $1 Bil. In Leverage From CBO Score (The Pink Sheet)

This is copyright protected information, to receive the full article, please click here to sign up and register.

Pharma Compliance Is Big Business; Software Vendors Offer Trove Of Tools (The Pink Sheet)

This is copyright protected information, to receive the full article, please click here to sign up and register.

Key Pharma Fraud Prosecutor Michael Loucks Leaving Post Of Acting U.S. Attorney In Boston (The Pink Sheet)

This is copyright protected information, to receive the full article, please click here to sign up and register.

Idera Pharmaceuticals, a biotechnology company, has reported that Merck & Co, through an affiliate, has extended its research collaboration with Idera for a fourth year. (Datamonitor.com)

FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder (PR Newswire)